Whole Exome Sequencing Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

Whole Exome Sequencing Market was valued at $733 Million in 2020 and is projected to reach $4256.3 Million in 2027, growing at a CAGR of 19% from 2021 to 2027.

Whole exome is a genomic technology that sequences all protein-coding regions of a gene in the genome. Whole exome sequencing (WES) is available to patients seeking an integrated diagnosis for multiple medical conditions. Exome sequencing using exome enrichment can efficiently detect coding variants in a wide range of applications including population genetics, genetic diseases, and cancer research. The growth of the global whole exome sequencing market is due to reduction in time and cost for sequencing, increasing need for molecular diagnostics and increasing application in drug discovery. However, ethical, social and legal challenges for whole exome sequencing and the lack of highly skilled professionals are major factors hampering the market growth.

Market Segmentation:

By Technology

• Sequencing by Synthesis
• Ion Semiconductor Sequencing
• Others

By Products and Services

• Products
• Systems
• Kits
• Services
• Sequencing Services
• Data Analysis Services
• Others

By Applications

• Diagnostics
• Cancer
• Monogenic Disorders
• Diabetes
• Others

Key Players

• Thermo Fisher Scientific Inc.
• F. Hoffmann-La Roche AG
• Psomagen, Inc. (previuosly Macrogen Corp.)
• Pacific Biosciences of California, Inc.
• Brooks Automation, Inc. (GENEWIZ, Inc.)
• Bio-Rad Laboratories, Inc.
• Eurofins Scientific

Scope of the Report

The research study analyzes the global Whole Exome Sequencing industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Whole Exome Sequencing Market Report

1. What was the Whole Exome Sequencing Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Whole Exome Sequencing Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Whole Exome Sequencing Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.